Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1975 Aug 2;3(5978):274–275. doi: 10.1136/bmj.3.5978.274

An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.

M R Glass, R W Shaw, W R Butt, R L Edwards, D R London
PMCID: PMC1674237  PMID: 1170923

Abstract

Fourteen patients with amenorrhoea and hyperprolactin-anemia but no evidence of pituitary tumours were each given an intramuscular injection of 1 mg oestradiol benzoate. Thirteen patients failed to release luteinizing hormone in response to the oestrogen. This hypothalamic abnormality may help to explain the menstrual disturbances in subjects with hyperprolactinaemia.

Full text

PDF
274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besser G. M., Parke L., Edwards C. R., Forsyth I. A., McNeilly A. S. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J. 1972 Sep 16;3(5828):669–672. doi: 10.1136/bmj.3.5828.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cargille C. M., Vaitukaitis J. L., Bermudez J. A., Ross G. T. A differential effect of ethinyl estradiol upon plasma FSH and LH relating to time of administration in the menstrual cycle. J Clin Endocrinol Metab. 1973 Jan;36(1):87–94. doi: 10.1210/jcem-36-1-87. [DOI] [PubMed] [Google Scholar]
  3. Friesen H., Hwang P. Human prolactin. Annu Rev Med. 1973;24:251–270. doi: 10.1146/annurev.me.24.020173.001343. [DOI] [PubMed] [Google Scholar]
  4. Gambrell R. D., Jr, Greenblatt R. B., Mahesh V. B. Post-pill and pill-related amenorrhea-galactorrhea. Am J Obstet Gynecol. 1971 Jul 15;110(6):838–848. doi: 10.1016/0002-9378(71)90581-3. [DOI] [PubMed] [Google Scholar]
  5. Lutterbeck P. M., Pryor J. S., Varga L., Wenner R. Treatment of non-puerperal galactorrhoea with an ergot alkaloid. Br Med J. 1971 Jul 24;3(5768):228–229. doi: 10.1136/bmj.3.5768.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McNatty K. P., Sawers R. S., McNeilly A. S. A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature. 1974 Aug 23;250(5468):653–655. doi: 10.1038/250653a0. [DOI] [PubMed] [Google Scholar]
  7. McNeilly A. S., Hagen C. Prolactin, TSH, LH and FSH responses to a combined LHRH-TRH test at different stages of the menstrual cycle. Clin Endocrinol (Oxf) 1974 Oct;3(4):427–435. doi: 10.1111/j.1365-2265.1974.tb02813.x. [DOI] [PubMed] [Google Scholar]
  8. McNeilly A. S. Radioimmunoassay of human prolactin. Proc R Soc Med. 1973 Sep;66(9):863–864. doi: 10.1177/003591577306600915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Monroe S. E., Jaffe R. B., Midgley A. R., Jr Regulation of human gonadotropins. XII. Increase in serum gonadotropins in response to estradiol. J Clin Endocrinol Metab. 1972 Feb;34(2):342–347. doi: 10.1210/jcem-34-2-342. [DOI] [PubMed] [Google Scholar]
  10. Mortimer C. H., Besser G. M., McNeilly A. S., Marshall J. C., Harsoulis P., Tunbridge W. M., Gomez-Pan A., Hall R. Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J. 1973 Oct 13;4(5884):73–77. doi: 10.1136/bmj.4.5884.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nillius S. J., Wide L. Induction of a midcycle-like peak of luteinizing hormone in young women by exogenous oestradiol-17. J Obstet Gynaecol Br Commonw. 1971 Sep;78(9):822–827. doi: 10.1111/j.1471-0528.1971.tb00345.x. [DOI] [PubMed] [Google Scholar]
  12. Redshaw M. R., Lynch S. S. An improved method for the preparation of iodinated antigens for radioimmunoassay. J Endocrinol. 1974 Mar;60(3):527–528. doi: 10.1677/joe.0.0600527. [DOI] [PubMed] [Google Scholar]
  13. Reyes F. I., Winter J. S., Faiman C. Pituitary-ovarian interrelationships during the puerperium. Am J Obstet Gynecol. 1972 Nov 1;114(5):589–594. doi: 10.1016/0002-9378(72)90833-2. [DOI] [PubMed] [Google Scholar]
  14. Rolland R., Schellekens L. A., Lequin R. M. Successful treatment of galactorrhoea and amenorrhoea and subsequent restoration of ovarian function by a new ergot alkaloid 2-brom-alpha-ergocryptine. Clin Endocrinol (Oxf) 1974 Apr;3(2):155–166. doi: 10.1111/j.1365-2265.1974.tb01791.x. [DOI] [PubMed] [Google Scholar]
  15. Shaw R. W., Butt W. R., London D. R., Marshall J. C. The oestrogen provocation test: a method of assessing the hypothalamic-pituitary axis in patients with amenorrhoea. Clin Endocrinol (Oxf) 1975 May;4(3):267–276. doi: 10.1111/j.1365-2265.1975.tb01534.x. [DOI] [PubMed] [Google Scholar]
  16. Shaw R. W., Butt W. R., London D. R., Marshall J. C. Variation in response to synthetic luteinizing hormone--releasing hormone (LH-RH) at different phases of the same menstrual cycle in normal women. J Obstet Gynaecol Br Commonw. 1974 Aug;81(8):632–639. doi: 10.1111/j.1471-0528.1974.tb00530.x. [DOI] [PubMed] [Google Scholar]
  17. Shaw R. W., Butt W. R., London D. R. Pathological mechanisms to explain some cases of amenorrhoea without organic disease. Br J Obstet Gynaecol. 1975 Apr;82(4):337–340. doi: 10.1111/j.1471-0528.1975.tb00645.x. [DOI] [PubMed] [Google Scholar]
  18. Shaw R. W. Estrogen modulation of gonadotrophin release. Proc R Soc Med. 1975 Feb;68(2):73–75. doi: 10.1177/003591577506800203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sinha Y. N., Selby F. W., Lewis U. J., VanderLaan W. P. A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973 Mar;36(3):509–516. doi: 10.1210/jcem-36-3-509. [DOI] [PubMed] [Google Scholar]
  20. Thorner M. O., McNeilly A. S., Hagan C., Besser G. M. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J. 1974 May 25;2(5916):419–422. doi: 10.1136/bmj.2.5916.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tsai C. C., Yen S. S. Acute effects of intravenous infusion of 17-beta-estradiol on gonadotropin release in pre- and post-menopausal women. J Clin Endocrinol Metab. 1971 Jun;32(6):766–771. doi: 10.1210/jcem-32-6-766. [DOI] [PubMed] [Google Scholar]
  22. Varga L., Wenner R., Del Pozo E. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility. Am J Obstet Gynecol. 1973 Sep 1;117(1):75–79. doi: 10.1016/0002-9378(73)90731-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES